MedPath

Human Gut Microbiota and Prebiotic Response

Not Applicable
Completed
Conditions
Healthy Gut Microbiota
Interventions
Dietary Supplement: Prebiotic A - inulin
Dietary Supplement: Prebiotic B - galactooligosaccharides(GOS)
Dietary Supplement: Prebiotic C - wheat dextrin
Registration Number
NCT03595306
Lead Sponsor
Duke University
Brief Summary

This study is designed to examine the shift in gut microbiota and their metabolism after consumption of a dietary supplement (prebiotic) by healthy participants. The investigators will provide participants with a panel of over the counter prebiotics and monitor their gut microbiome response in stool. All prebiotics will be commercially available, over-the-counter food, food additives, or dietary supplements, without any known market-use adverse effects beyond minimal discomfort.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • Provide Stool Samples at no risk to yourself
Read More
Exclusion Criteria
  • No oral antibiotic treatments within previous 1 month
  • No known allergy to milk products or lactose intolerance
  • no known allergy to wheat or gluten intolerance
  • no history of irritable bowel syndrome
  • no history of inflammatory bowel disease
  • no history of type-2 diabetes
  • no history of chronic kidney disease or reduced kidney function
  • no current intestinal obstructions
  • no current untreated colorectal cancer
  • not currently pregnant or breastfeeding
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Prebiotic APrebiotic B - galactooligosaccharides(GOS)-
Prebiotic CPrebiotic C - wheat dextrin-
Prebiotic CPrebiotic B - galactooligosaccharides(GOS)-
Prebiotic CPrebiotic A - inulin-
Prebiotic BPrebiotic B - galactooligosaccharides(GOS)-
Prebiotic APrebiotic A - inulin-
Prebiotic APrebiotic C - wheat dextrin-
Prebiotic BPrebiotic A - inulin-
Prebiotic BPrebiotic C - wheat dextrin-
Primary Outcome Measures
NameTimeMethod
change in levels of SCFAs in stool samplesBaseline and 6 weeks
Secondary Outcome Measures
NameTimeMethod
change in levels of cytokines in stool samplesBaseline and 6 weeks

Trial Locations

Locations (1)

Duke University

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath